Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Journal
Clinical Cancer Research
Journal Volume
27
Journal Issue
23
Pages
6413-6423
Date Issued
2021
Author(s)
Even C.
Wang H.-M.
Li S.-H.
Ngan R.K.-C.
Dechaphunkul A.
Zhang L.
Yen C.-J.
Chan P.C.
Chakrabandhu S.
Ma B.B.Y.
Tanasanvimon S.
Lee V.H.F.
Li Z.
Spira A.I.
Sukari A.
Guigay J.
McCune S.
Gonzalez-Maffe J.
Szpakowski S.
Yao Y.
Liang H.
Mataraza J.
Sechaud R.
Manenti L.
Lim D.W.-T.
SDGs
Publisher
American Association for Cancer Research Inc.
Type
journal article